Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 26 May | 100.50 |
5.30 (5.57%) |
OPEN
95.40 |
HIGH
101.40 |
LOW
93.50 |
| NSE 00:00 | 26 May | 100.60 |
5.35 (5.62%) |
OPEN
94.20 |
HIGH
101.90 |
LOW
93.10 |
| OPEN | 95.40 |
| PREVIOUS CLOSE | 95.20 |
| VOLUME | 2510 |
| 52-Week high | 148.50 |
| 52-Week low | 88.00 |
| P/E | 15.37 |
| Mkt Cap.(Rs cr) | 156 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 0.68 | 2.20 | 2.58 |
| Net Cash From Operating Activities | 10.24 | 21.71 | 11.55 |
| Net Cash Used In/from Investing Activities | -6.66 | -3.30 | -11.98 |
| Net Cash Used In/from Financing Activities | -3.36 | -19.94 | 0.05 |
| Net (decrease)/increase In Cash and Cash Equivalents |
0.21 | -1.52 | -0.38 |
| Closing Cash & Cash Equivalents | 0.89 | 0.68 | 2.20 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
